The Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK)

NCT01271894 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Efavirenz
DRUG: Efavirenz

Sponsor

Kirby Institute

Collaborators

[object Object]